For the first time, scientists discover that a subset of a common blood cancer is more deadly in women than in men — and find a new targeted treatment approach
New biomedical proteomics unit to boost personalised medicine, led by IRB Barcelona in collaboration with the Josep Carreras Leukaemia Research Institute
Dr. Manel Esteller, director of the Josep Carreras Leukaemia Research Institute, recognized among the scientists with the most impact according to Stanford University
